𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The influence of CD95L expression on tumor rejection in mice

✍ Scribed by Frederik H. Igney; Christian K. Behrens; Peter H. Krammer


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
362 KB
Volume
33
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Expression of the tumor-rejection antige
✍ Toshihiro Imaizumi; Terukazu Kuramoto; Kazuko Matsunaga; Shigeki Shichijo; Shige 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 156 KB 👁 2 views

We have reported a tumor-rejection antigen, SART1 259 , possessing tumor epitopes capable of inducing cytotoxic T lymphocytes (CTLs) in epithelial-cancer patients. This study investigated the expression of SART1 259 antigen in brain tumors, to explore for a potential molecule for use in specific imm

Expression of the SART-1 tumor rejection
✍ Mayumi Kawamoto; Shigeki Shichijo; Yasuhisa Imai; Toshihiko Imaizumi; Toshihiro 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 127 KB 👁 2 views

We investigated in breast cancers the expression of the SART-1 gene encoding tumor rejection antigens. SART-1 mRNA was expressed in all of the samples tested. The SART-1 800 antigen was detectable in 20 of 50 (40%) breast cancer tissues and all breast cancer cell lines tested, but not in normal brea

Influence of glutathione S-transferase p
✍ Laurent Gate; Rajrupa S. Majumdar; Alexandra Lunk; Kenneth D. Tew 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 233 KB

## Abstract The role of glutathione S‐transferase π (GSTπ) in tumor development has been previously suggested; however the exact function of this enzyme in carcinogenesis remains unclear. GSTπ has been identified as a modulator of cell signaling by interacting with and inhibiting c‐Jun N‐terminal k

Influence of MUC18/MCAM/CD146 expression
✍ Hermine Schlagbauer-Wadl; Burkhard Jansen; Markus Müller; Peter Polterauer; Klau 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 78 KB 👁 1 views

The cell surface glycoprotein MUC18MCAM/CD146 was originally defined as a marker of melanoma progression and has been suspected to be directly linked to the metastatic process of this malignancy. In order to address this question, 2 MCAM negative human melanoma cell lines, SK-2 and XP44RO(Mel), were